Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jeremy Nichols

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Nature Genetics|December 2, 2015
Multisystem Lewy body disease and the other parkinsonian disordersJ William Langston, Birgitt Schüle, Linda Rees, et al.
Journal of Neurochemistry|October 19, 2011
Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson's disease mutations and LRRK2 pharmacological inhibitionElizabeth A Doggett, Jing Zhao, Christina N Mork, et al.
Biology of Reproduction|August 22, 2009
Mice deficient in the serine/threonine protein kinase VRK1 are infertile due to a progressive loss of spermatogoniaMatthew S Wiebe, R Jeremy Nichols, Tyler P Molitor, et al.
Frontiers in Molecular Neuroscience|July 11, 2014
LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site statusApril Reynolds, Elizabeth A Doggett, Steve M Riddle, et al.
The Biochemical Journal|April 24, 2007
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activityMahaboobi Jaleel, R Jeremy Nichols, Maria Deak, et al.
The Biochemical Journal|July 28, 2010
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localizationNicolas Dzamko, Maria Deak, Faycal Hentati, et al.
Biochemical Society Transactions|September 20, 2012
Pharmacological inhibition of LRRK2 cellular phosphorylation sites provides insight into LRRK2 biologyJing Zhao, Spencer B Hermanson, Coby B Carlson, et al.
Plos One|September 7, 2012
Screening for novel LRRK2 inhibitors using a high-throughput TR-FRET cellular assay for LRRK2 Ser935 phosphorylationSpencer B Hermanson, Coby B Carlson, Steven M Riddle, et al.
Cell Reports|May 4, 2023
Dissecting the effects of GTPase and kinase domain mutations on LRRK2 endosomal localization and activityCapria Rinaldi, Christopher S Waters, Zizheng Li, et al.
The Biochemical Journal|September 11, 2009
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's diseaseR Jeremy Nichols, Nicolas Dzamko, Jessica E Hutti, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Nature Genetics|December 2, 2015
Multisystem Lewy body disease and the other parkinsonian disordersJ William Langston, Birgitt Schüle, Linda Rees, et al.
Journal of Neurochemistry|October 19, 2011
Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson's disease mutations and LRRK2 pharmacological inhibitionElizabeth A Doggett, Jing Zhao, Christina N Mork, et al.
Biology of Reproduction|August 22, 2009
Mice deficient in the serine/threonine protein kinase VRK1 are infertile due to a progressive loss of spermatogoniaMatthew S Wiebe, R Jeremy Nichols, Tyler P Molitor, et al.
Frontiers in Molecular Neuroscience|July 11, 2014
LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site statusApril Reynolds, Elizabeth A Doggett, Steve M Riddle, et al.
The Biochemical Journal|April 24, 2007
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activityMahaboobi Jaleel, R Jeremy Nichols, Maria Deak, et al.
The Biochemical Journal|July 28, 2010
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localizationNicolas Dzamko, Maria Deak, Faycal Hentati, et al.
Biochemical Society Transactions|September 20, 2012
Pharmacological inhibition of LRRK2 cellular phosphorylation sites provides insight into LRRK2 biologyJing Zhao, Spencer B Hermanson, Coby B Carlson, et al.
Plos One|September 7, 2012
Screening for novel LRRK2 inhibitors using a high-throughput TR-FRET cellular assay for LRRK2 Ser935 phosphorylationSpencer B Hermanson, Coby B Carlson, Steven M Riddle, et al.
Cell Reports|May 4, 2023
Dissecting the effects of GTPase and kinase domain mutations on LRRK2 endosomal localization and activityCapria Rinaldi, Christopher S Waters, Zizheng Li, et al.
The Biochemical Journal|September 11, 2009
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's diseaseR Jeremy Nichols, Nicolas Dzamko, Jessica E Hutti, et al.
Pageof 4